Mallinda’s Vitrimax™ VHM Resin Enables Economically Viable Composite Recycling “`

DENVER, January 3, 2025 — Mallinda Inc., a leader in advanced polymer technology, today announced the commercial availability of Vitrimax™ Versatile Hot Melt (VHM) Resin. This innovative vitrimer-based composite resin system revolutionizes high-performance composite processing and recycling. This technology uniquely blends the superior mechanical properties of thermosets with the processing…

LPOXY Therapeutics Acquires Xeno Biosciences Assets to Advance C. difficile Prevention Therapy “`

PLATTE CITY, Mo., Jan. 3, 2025 — LPOXY Therapeutics, Inc. (“LPOXY”), a clinical-stage biopharmaceutical company specializing in innovative infectious disease prevention therapies, announced a term sheet agreement to acquire key assets from Xeno Biosciences Inc. (“Xeno”). These assets encompass regulatory filings, communications, and documentation from FDA and global regulatory interactions,…

FDA News Summary for January 3, 2025 “`

SILVER SPRING, Md., Jan. 3, 2025 — The U.S. Food and Drug Administration (FDA) offers a summary of recent agency news: The FDA declared 35 food contact notifications (FCNs) related to per- and polyfluoroalkyl substances (PFAS) abandoned. Manufacturers ceased production, supply, or use of these substances, previously used in grease-proofing…